RxDoctor Payments Data

Alexander Yuan, DO

Cardiovascular Disease · Biloxi, MSNPI 1497287189

Payments from drug & device makers

$376in general payments, 2019–2025

Across 19 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$161
  • Amgen$70
  • AstraZeneca$36
  • AbbVie$26
  • United Therapeutics Corporation$26
  • Werfen USA LLC$22
  • plus $35 from 2 others

What the payments were for

  • Food & beverage$376100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abiomed8$161
Amgen4$70
AstraZeneca2$36
AbbVie1$26
United Therapeutics Corporation1$26
Werfen USA LLC1$22
Boston Scientific1$18
Novartis1$17

How this compares

$376 in reported general payments places this provider in the 15th percentile of 144 cardiovascular disease providers in Mississippi.

See all cardiovascular disease providers in Mississippi

Medicare billing

Part B allowed, 2024
$1,023
Medicare patients
12
Services billed
12

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Biloxi

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →